AYTU BIOPHARMA, INC Quarterly Common Stock, Shares, Outstanding from Q3 2011 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Aytu Biopharma, Inc quarterly Common Stock, Shares, Outstanding history and growth rate from Q3 2011 to Q2 2024.
  • Aytu Biopharma, Inc Common Stock, Shares, Outstanding for the quarter ending June 30, 2024 was 5.97M shares, a 8.26% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 5.97M +455K +8.26% Jun 30, 2024 10-K 2024-09-26
Q1 2024 5.57M +1.79M +47.3% Mar 31, 2024 10-Q 2024-05-15
Q4 2023 5.57M +2.18M +64.6% Dec 31, 2023 10-Q 2024-02-14
Q3 2023 5.53M +2.41M +77.2% Sep 30, 2023 10-Q 2023-11-14
Q2 2023 5.52M +3.59M +186% Jun 30, 2023 10-K 2024-09-26
Q1 2023 3.78M -29.6M -88.7% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 3.38M -26.6M -88.7% Dec 31, 2022 10-Q 2023-02-21
Q3 2022 3.12M -24.7M -88.8% Sep 30, 2022 10-Q/A 2023-02-21
Q2 2022 1.93M -25.6M -93% Jun 30, 2022 10-K 2023-10-12
Q1 2022 33.4M +9.9M +42.2% Mar 31, 2022 10-Q 2022-05-16
Q4 2021 30M +12.1M +67.8% Dec 31, 2021 10-Q 2022-02-14
Q3 2021 27.8M -98.1M -77.9% Sep 30, 2021 10-Q 2021-11-15
Q2 2021 27.5M +14.9M +118% Jun 30, 2021 10-K 2022-09-27
Q1 2021 23.5M -77.2M -76.7% Mar 31, 2021 10-Q 2021-05-17
Q4 2020 17.9M -2.85M -13.7% Dec 31, 2020 10-Q 2021-02-11
Q3 2020 126M +108M +600% Sep 30, 2020 10-Q 2020-11-12
Q2 2020 12.6M -4.95M -28.2% Jun 30, 2020 10-K 2021-09-28
Q1 2020 101M +87.8M +683% Mar 31, 2020 10-Q 2020-05-15
Q4 2019 20.7M +10.2M +97.4% Dec 31, 2019 10-Q 2020-02-14
Q3 2019 18M +16.2M +898% Sep 30, 2019 10-Q 2019-11-14
Q2 2019 17.5M +15.7M +877% Jun 30, 2019 10-K 2020-10-06
Q1 2019 12.8M -23M -64.1% Mar 31, 2019 10-Q 2019-05-14
Q4 2018 10.5M +5.61M +115% Dec 31, 2018 10-Q/A 2019-05-14
Q3 2018 1.8M -2.42M -57.4% Sep 30, 2018 10-Q 2018-11-07
Q2 2018 1.79M +1.75M +4252% Jun 30, 2018 10-K 2019-09-26
Q1 2018 35.8M +22M +159% Mar 31, 2018 10-Q 2018-05-14
Q4 2017 4.89M -5.95M -54.9% Dec 31, 2017 10-Q 2018-02-08
Q3 2017 4.22M -886K -17.3% Sep 30, 2017 10-Q 2017-11-09
Q2 2017 41.2K -146K -78% Jun 30, 2017 10-K 2018-09-06
Q1 2017 13.8M -8.61M -38.4% Mar 31, 2017 10-Q 2017-05-11
Q4 2016 10.8M -3.41M -23.9% Dec 31, 2016 10-Q 2017-02-09
Q3 2016 5.11M -9.15M -64.2% Sep 30, 2016 10-Q 2016-11-07
Q2 2016 187K -1M -84.3% Jun 30, 2016 10-K 2017-08-31
Q1 2016 22.4M +3.01M +15.5% Mar 31, 2016 10-Q 2016-05-11
Q4 2015 14.3M +8.42M +144% Dec 31, 2015 10-Q 2016-02-11
Q3 2015 14.3M +8.52M +149% Sep 30, 2015 10-Q 2015-11-06
Q2 2015 1.19M -6.71M -85% Jun 30, 2015 10-K 2016-09-01
Q1 2015 19.4M +14.5M +295% Mar 31, 2015 10-Q 2015-05-19
Q4 2014 5.84M +918K +18.7% Nov 30, 2014 10-Q 2015-01-12
Q3 2014 5.74M +838K +17.1% Aug 31, 2014 10-Q 2015-04-15
Q2 2014 7.9M +3.01M +61.6% Jun 30, 2014 10-K 2015-09-30
Q1 2014 4.92M +28K +0.57% Feb 28, 2014 10-Q 2014-04-11
Q4 2013 4.92M +28K +0.57% Nov 30, 2013 10-Q 2014-01-10
Q3 2013 4.9M +41.3K +0.85% Aug 31, 2013 10-K 2014-11-26
Q2 2013 4.89M +74.8K +1.55% May 31, 2013 10-Q 2013-06-28
Q1 2013 4.89M +74.8K +1.55% Feb 28, 2013 10-Q 2013-04-15
Q4 2012 4.89M +115K +2.41% Nov 30, 2012 10-Q 2013-01-14
Q3 2012 4.86M +121K +2.56% Aug 31, 2012 10-K 2014-11-26
Q2 2012 4.81M May 31, 2012 10-Q 2012-06-26
Q1 2012 4.81M Feb 29, 2012 10-Q 2012-04-12
Q4 2011 4.77M Nov 30, 2011 10-Q 2011-12-23
Q3 2011 4.73M Aug 31, 2011 10-K 2012-11-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.